Guidance

Supply unlicensed medicinal products (specials)

Guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials'

From:
Medicines and Healthcare products Regulatory Agency
Published
6 May 2014
Last updated
29 January 2025 바카라 사이트” See all updates

Documents

Supply unlicensed medicinal products (specials)

HTML

PDF, 527 KB, 21 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PDF, 795 KB, 22 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This Medicines and Healthcare products Regulatory Agency (MHRA) guidance is for those who want to manufacture, import, distribute or supply unlicensed medicines for human use (also known as 바카라 사이트˜specials바카라 사이트™), includingĀ CBPMs.

바카라 사이트˜Specials바카라 사이트™ are products which have been specially manufactured or imported for the treatment of an individual patient after being ordered by a:

  • doctor
  • dentist
  • nurse independent prescriber
  • pharmacist independent prescriber
  • supplementary prescriber

Persons authorised to procure unlicensedĀ CBPMsĀ in the UK are:

  • doctors on the GMC Specialist Register
  • specialist Importers with a Home Office import and Domestic licence and MHRA licence
  • registered pharmacies or retail pharmacy businesses (with Home Office Domestic licences, where appropriate)
  • licensed wholesale dealers for supply to the order of any of the above

Updates to this page

Published 6 May 2014
Last updated 29 January 2025 show all updates

  1. A new Guidance document, complementary to MHRA Guidance note 14, has been included linking different government pages of interest to the supply unlicensed medicinal products in the UK.

  2. Updated PDF for 'The supply of unlicensed medicinal products 'specials', MHRA guidance note 14'

  3. Updated to add guidance on manufacturing, importing, distributing and supplying specially manufactured or ordered cannabis-based products for medicinal use in humans (CBPMs) known as 'specials'.

  4. First published.

Sign up for emails or print this page

Related content